Mary B Cranston - Net Worth and Insider Trading
Mary B Cranston Net Worth
The estimated net worth of Mary B Cranston is at least $5 Million dollars as of 2024-11-08. Mary B Cranston is the Director of Visa Inc and owns about 11,096 shares of Visa Inc (V) stock worth over $3 Million. Mary B Cranston is the Director of The Chemours Co and owns about 36,018 shares of The Chemours Co (CC) stock worth over $712,796. Mary B Cranston is also the Director of Exponent Inc and owns about 4,896 shares of Exponent Inc (EXPO) stock worth over $515,108. Besides these, Mary B Cranston also holds Juniper Networks Inc (JNPR) , Mellanox Technologies Ltd (MLNX) , MyoKardia Inc (MYOK) . Details can be seen in Mary B Cranston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mary B Cranston has not made any transactions after 2021-02-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mary B Cranston
Mary B Cranston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mary B Cranston owns 9 companies in total, including MyoKardia Inc (MYOK) , The Chemours Co (CC) , and Visa Inc (V) among others .
Click here to see the complete history of Mary B Cranston’s form 4 insider trades.
Insider Ownership Summary of Mary B Cranston
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MYOK | MyoKardia Inc | 2020-06-30 | director |
CC | The Chemours Co | 2019-08-07 | director |
V | Visa Inc | 2021-02-18 | director |
2018-01-22 | 10 percent owner & other: See Explanation of Responses | ||
2013-05-21 | director | ||
2013-05-10 | director | ||
2009-01-15 | director | ||
2020-10-22 | director | ||
2022-01-13 | director |
Mary B Cranston Latest Holdings Summary
Mary B Cranston currently owns a total of 6 stocks. Among these stocks, Mary B Cranston owns 11,096 shares of Visa Inc (V) as of February 18, 2021, with a value of $3 Million and a weighting of 66.69%. Mary B Cranston owns 36,018 shares of The Chemours Co (CC) as of August 7, 2019, with a value of $712,796 and a weighting of 13.81%. Mary B Cranston also owns 4,896 shares of Exponent Inc (EXPO) as of May 10, 2013, with a value of $515,108 and a weighting of 9.98%. The other 3 stocks Juniper Networks Inc (JNPR) , Mellanox Technologies Ltd (MLNX) , MyoKardia Inc (MYOK) have a combined weighting of 9.52% among all his current holdings.
Latest Holdings of Mary B Cranston
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
V | Visa Inc | 2021-02-18 | 11,096 | 310.28 | 3,442,867 |
CC | The Chemours Co | 2019-08-07 | 36,018 | 19.79 | 712,796 |
EXPO | Exponent Inc | 2013-05-10 | 4,896 | 105.21 | 515,108 |
JNPR | Juniper Networks Inc | 2012-05-22 | 11,898 | 38.96 | 463,487 |
MLNX | Mellanox Technologies Ltd | 2018-01-22 | 223 | 124.89 | 27,850 |
MYOK | MyoKardia Inc | 2020-06-30 | 0 | 224.91 | 0 |
Holding Weightings of Mary B Cranston
Mary B Cranston Form 4 Trading Tracker
According to the SEC Form 4 filings, Mary B Cranston has made a total of 1 transactions in Visa Inc (V) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Visa Inc is the sale of 4,900 shares on February 18, 2021, which brought Mary B Cranston around $1 Million.
According to the SEC Form 4 filings, Mary B Cranston has made a total of 0 transactions in The Chemours Co (CC) over the past 5 years. The most-recent trade in The Chemours Co is the acquisition of 1,790 shares on August 7, 2019, which cost Mary B Cranston around $25,042.
According to the SEC Form 4 filings, Mary B Cranston has made a total of 0 transactions in Exponent Inc (EXPO) over the past 5 years. The most-recent trade in Exponent Inc is the sale of 7,440 shares on May 10, 2013, which brought Mary B Cranston around $99,510.
More details on Mary B Cranston's insider transactions can be found in the Insider Trading History of Mary B Cranston table.Insider Trading History of Mary B Cranston
- 1
Mary B Cranston Trading Performance
GuruFocus tracks the stock performance after each of Mary B Cranston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mary B Cranston is 1.63%. GuruFocus also compares Mary B Cranston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mary B Cranston within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mary B Cranston's insider trading performs compared to the benchmark.
Performance of Mary B Cranston
Mary B Cranston Ownership Network
Ownership Network List of Mary B Cranston
Ownership Network Relation of Mary B Cranston
Mary B Cranston Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Mary B Cranston is the director of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Mary B Cranston Mailing Address
Above is the net worth, insider trading, and ownership report for Mary B Cranston. You might contact Mary B Cranston via mailing address: C/o Visa Inc., P.o. Box 8999, San Francisco Ca 94128-8999.